Researchers from the Metabolism and Cancer group (ICO-IDIBGI) and Mayo Clinic discover a strategy that enhances cell death in one of the most aggressive tumors. A team of researchers from the ProCURE program at the Catalan Institute of Oncology (ICO) Girona-Institute of Biomedical Research of Girona (IDIBGI), …

Silibinin, a natural molecule from milk thistle, blocks a key protein in cancer metastasis that has so far resisted therapeutic manipulation. A study by the Girona Biomedical Research Institute (IDIBGI) and the Catalan Institute of Oncology (ICO) has identified an inhibitor of a key protein in …

•  Focusing on modifiable risk factors, the project aims to reduce the global impact of breast cancer, a significant health challenge worldwide. •  Multidisciplinary experts will conduct a thorough analysis of national cancer plans and design innovative interventions that will be tailored to specific regions.

The project will make possible the classification of the different types of breast cancer and predict the probability of metastasis thanks to the joint analysis of radiological and microscopic images. It will be led by researcher Domènec Puig from the Institut d’Investigació Sanitària Pere Virgili …

21 – 23 November 2022 was the Kick-off Meeting of CGI-Clinics, a five-year project funded by the European Union and UK Research and Innovation, which started on 01 November. 60 participants from the 17 member institutions of the consortium met in Empúries (Girona, Spain). The …

Research led by the Departments of Dermatology, Pathology and Molecular Genetics of the Hospital Universitari Arnau de Vilanova de Lleida (HUAV) and the Oncological Pathology research group of the Universitat de Lleida (UdL) and the Institute for Research in Biomedicine of Lleida (IRBLleida) has identified …

Colorectal cancer (CRC) is the most frequent neoplasm in Western countries, the second most frequent neoplasm after breast cancer in women and the third most frequent neoplasm after prostate and lung cancer in men. Survival at five years, if all stages are taken into account, …

The Medical Imaging Research Group at IDIBGI receives funding to carry out the ProCAncer-I project, which aims to develop a platform to support clinical decision making in prostate cancer through medical imaging and artificial intelligence. ProCAncer-I project brings together 20 partners from 11 different …

The OP&B team are collaborating with the fundraising initiative “Project Emma” (http://projecteemma.org/). The project is an initiative of the Doctor Ferran Foundation and aims to find to develop computer-aided digital image analysis patterns for quantitative automated evaluation of specific markers of tumour and non-tumour …

A study led by the Medical Oncology faculty of the Arnau de Vilanova de Lleida University Hospital and researcher at the Lleida Biomedical Research Institute (IRBLleida), Serafín Morales, which investigates a personalized treatment for early stages of breast cancer, has been selected by the …

An international study that has just been published in the scientific journal The New England Journal of Medicine has shown that the administration of niraparib after conventional chemotherapy in patients with newly diagnosed advanced ovarian cancer improves their progression-free survival and reduces the risk of …

This research will help to identify those genes that play a key role in the initiation of metastasis The research, led by Andreu Casali from the Institut de Recerca Biomedica de Lleida (IRBLleida) and the University of Lleida (UdL) together with Kyra Campbell, from …